Search Results
Dr. Bunn Discusses Afatinib in Lung Cancer
Dr. Bunn Discusses Afatinib for Patients with EGFR mutation
Dr. Bunn Discusses the Need to Study Drug Combinations in Lung Cancer
Dr. Bunn on the Response of Immunotherapy in Lung Cancer
Dr. Bunn on Combining Immunotherapy and Chemotherapy in Lung Cancer
Dr. Bunn Discusses the Potential Benefit for a Blood-Based Test to Detect a T790M Mutation
Dr. Bunn on Treating Advanced-Stage Lung Cancer with TKIs
Dr. Mok on the Utility of Afatinib in Lung Cancer
Afatinib Plus Cetuximab in Resistant Non-Small Cell Lung Cancer
Dr. Chachoua on Afatinib for Exon 19 Mutation in Lung Cancer
Afatinib in Patients With Uncommon EGFR Mutations
Study of 693 NSCLC patients treated with afatinib
